To investigate the relationship between left atrial (LA) size, endothelial dysfunction and different markers of target organ damage (TOD), we measured left atrial diameter (LAD) and endothelial function in hypertensive patients with or without TOD. In this study, 197 patients with hypertension were divided into four groups as follows: no TOD (Group I, n ¼ 40), one TOD (Group II, n ¼ 76), two TOD (Group III, n ¼ 46) and X3 TOD (Group IV, n ¼ 35). Endothelial function was assessed by endothelium-dependent vasodilatation (flow-mediated dilation, FMD) of the brachial artery. We also assessed serum creatinine, the urinary albumincreatinine ratio (UACR), the intima-media thickness (IMT) of the common carotid, carotid to femoral pulse wave velocity (cf-PWV) and left ventricular mass index (LVMI). Our results were as follows: LA size was increased in 50.8% of patients and was associated with the number of TOD. LAD was larger in the patient groups with X3 TOD as compared with patients with two TOD, one TOD and no TOD. FMD was lower in patients with LAD enlargement. LAD exhibited significant relationships with serum creatinine, UACR, cf-PWV, IMT and LVMI. In stepwise multivariate regression analysis, LVMI In conclusions, enlargement of LAD may be an important predictor of endothelial dysfunction and may be considered to be an indicator for evaluating TOD in hypertensive patients.
Introduction
Left atrial (LA) size, as measured by a single M-mode dimension, is associated with the presence of cardiovascular disease and is predictive of stroke, atrial fibrillation and death. [1] [2] [3] [4] Furthermore, it may be an early sign of patients with hypertensive heart disease. 5 Increased levels of systolic and pulse pressure (PP) were significantly associated with increased LA size. 6 Left ventricular hypertrophy (LVH), carotid wall thickening or plaque buildup, alteration of arterial stiffness, microalbuminuria (MA) and a slight increase in serum creatinine are well-recognized markers of target organ damage (TOD) of adverse prognostic significance in hypertensive patients. [7] [8] [9] [10] [11] Flow-mediated dilation (FMD) is an appropriate method to study endothelial function. Although the mechanism of the relationship between hypertension and endothelial dysfunction is unknown, it has been proposed that endothelial dysfunction causes hypertension and that hypertension aggravates the impairment of endothelial function. 12 We found that reduced FMD was associated with the number of TOD and may be considered an indicator for evaluating TOD. 13 However, little is known about the relationship between LA size, endothelial dysfunction and the number of TOD in hypertensive patients. Therefore, we investigated the correlation between left atrial diameter (LAD), FMD and different markers of TOD in uncomplicated hypertensive patients.
Methods
All experiments in this study were approved by the ethical committee of the Shanghai Jiao Tong University School of Medicine. All subjects provided their informed, written consent before participation.
Study population
The study population consisted of 197 (114 males, 83 females) consecutive patients with hypertension recruited from the outpatient clinic of Shanghai Ninth People's Hospital, Shanghai, People's Republic of China. Exclusion criteria included: cardiac valve disease, atrial fibrillation, myocardial infarction, angina, coronary revascularization, heart failure, ischaemic stroke, cerebral haemorrhage, transient ischaemic attack, diabetic nephropathy, renal impairment (serum creatinine M4133, W4124 mmol l À1 ), proteinuria (4300 mg per 24 h), peripheral artery disease, advanced retinopathy and tumour. Patients with suspected secondary hypertension were also excluded.
Participants underwent physical examination and blood tests to assess cardiovascular risk factors, including age, gender, waist, waist-hip ratio, body mass index (BMI), smoking, the course of hypertension history, systolic blood pressure (SBP), diastolic blood pressure (DBP), PP, serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), hypersensitive C-reactive protein, serum creatinine, uric acid, urinary albumin-creatinine ratio (UACR) and intima-media thickness (IMT) of the common carotid. Plasma glucose was measured before (fasting) and 120 min after oral ingestion of 75 g of glucose. They were asymptomatic, and diabetes was defined by a fasting glucose level above 126 mg dl À1 and/or 2-h glucose level above 200 mg dl À1 . 15 Echocardiography LA size was determined in the parasternal long-axis view using a leading edge to leading edge measurement of the maximal distance between the posterior aortic root wall and the posterior LA wall at end systole, according to the American Society of Echocardiography guidelines. 16 All of the examinations and offline measurements were conducted using a HD11XE ultrasound machine (Philips Medical Systems, Andover, MA, USA) with a 2-4 MHz transducer. The left atrium was considered enlarged when the LAD exceeded 40 mm, according to the guidelines of the Chinese Society of Echocardiography. The echocardiographers were blinded to the results of the TOD measurements. The interobserver and intraobserver variabilities for measuring LA dimension have been compared in 60 consecutive measurements and were 4.7 and 3.2%, respectively, in our laboratory.
Definition of TOD

Assessment of brachial artery endothelial function
Both the endothelium-dependent and -independent vasodilatation of the brachial artery were assessed by high-resolution ultrasound (CX50 ultrasound systems, Philips Medical Systems), as described previously. 17 In brief, diameter measurements of the right brachial artery were taken at rest and during reactive hyperaemia after occlusion by inflation at least 50 mm Hg above systolic pressure for 5 min in the upper arm. After 15 min, the endotheliumindependent response was assessed by the change in artery diameter at 3 min after a 400-mg dose of sublingual nitroglycerin (NTG). All scans were recorded by a computer for analysis. The parameters were measured for three consecutive cardiac cycles with the top of the R wave on the electrocardiogram, and the average was taken. The ultrasounds scans were analysed by one observer. The coefficients of variation of FMD and NTG for repeated within-subject measurements were 3.1 and 3.5%, respectively.
Measurement of arterial stiffness
Cf-PWV was measured automatically using a Complior SP device (Artech-Medical Co., Paris, France) following the methods described previously. 18 Briefly, two transducers were placed at the base of the neck for the common carotid artery and over the femoral artery. The two transducers were positioned to record the best signals. The transit time between the carotid and femoral pulse waves was determined automatically by the software. The distance between the two recording sites was measured, allowing PWV to be calculated as the ratio of the distance to the transit time. The coefficient of variation of the cf-PWV for repeated within-subject measurement was 0.8%.
Statistical analysis
Data are presented as mean ± s.d., unless otherwise stated. Within the patient group, Pearson's correlation analysis was used to identify possible relationships between LAD and cardiovascular risk factors and TOD. Multiple regression models were constructed to evaluate the independent contributions of different factors on FMD and LAD. First, a stepwise multiple regression analysis was performed to evaluate the independent determinants of FMD using age, gender, BMI, smoking, diabetes mellitus (DM), hypertension history, SBP, PP, serum creatinine, TC, TG, LDL-C, E/A, UACR, cf-PWV, IMT, LVMI and LAD. Then, using the LAD as the dependent variable, age, gender, BMI, smoking, DM, hypertension history, SBP, PP, serum creatinine, TC, TG, LDL-C, E/A, UACR, cf-PWV, IMT, LVMI and FMD were designated as the independent variables. One-way analysis of variance was used to compare LAD among the four groups of patients with different numbers of TOD. Statistical significance was defined as Po0.05. All statistical analyses were performed using SPSS Version 11.5 (SPSS Inc., Chicago, IL, USA).
Results
Patient population
Of the 197 patients, 58% were men and 42% were women, with respective mean ages of 58 ± 11 and 58±8 years; 8.6% had DM, 31.5% were smokers and 85.9% had a family history of hypertension; 40 patients had no TOD, 76 had damage in one target organ, 46 had 2 TOD and 35 had X3 TOD (Table 1) . Patients in the hypertensive population were using oral antihypertensive agents, including diuretics (n ¼ 14), angiotensin-converting enzyme inhibitors (n ¼ 50), angiotensin II receptor blockers (n ¼ 46), calcium antagonists (n ¼ 101) and b-blockers (n ¼ 47). We analysed the drug ratio in different groups and found that there were no significant differences of the proportion of antihypertensive medications in different groups.
Prevalence rates of the various markers of TOD In this study population, the prevalence of LAD enlargement, alteration of arterial stiffness, IMT thickening or plaque buildup, LVH, microalbuminuria and a slight increase in serum creatinine was 50.8, 49.4, 40.1, 38.7, 24.7 and 1.6%, respectively ( Figure 1 ).
Correlation of LAD with clinical variables
Univariate analysis identified a relationship between LAD and cardiovascular risk factors: age and FMD (r ¼ À0.367, Po0.001) (Figure 2 ). However, there was no relationship between LAD and DBP, blood fasting glucose, postprandial glucose, TC, TG or LDL-C.
Univariate analysis confirmed a significant relationship between LAD and TOD: UACR (r ¼ 0.176, P ¼ 0.016), serum creatinine (r ¼ 0.177, P ¼ 0.014), cf-PWV (r ¼ 0.182, P ¼ 0.020), IMT (r ¼ 0.300, Po0.001) and LVMI (r ¼ 0.546, P ¼ 0.001).
Multiple regression models were constructed to evaluate the independent contributions of different factors on FMD and LAD. We found that (Table 2) .
LAD and number of TOD LAD was significantly enlarged with the total number of TOD increased. Adjust for age, sex and BMI, LAD was larger in the patient groups with X3 TOD as compared with patients with two TOD (Group IV: 41.8 ± 0.6 mm vs Group III: 40.2 ± 0.5 mm, Po0.05), one TOD (Group II: 39.9 ± 0.4 mm, Po0.05) and no TOD group (Group I: 39.5±0.6 mm, Po0.05) ( ± s.e.) (Figure 3) . FMD in patients with (I) or without (II) LAD enlargement LAD enlargement was found in 100 patients out of 197, with an overall prevalence of 50.8% (Table 3) . Adjusted for age, gender, BMI, waist size, waist-hip ratio, SBP, DBP, PP, TG, TC, HDL-C, LDL-C, plasma glucose, smoking, DM and duration of hypertension, FMD was still lower in patients with LA enlargement (8.14 ± 0.68 vs 10.95 ± 0.64%, Po0.01) ( ± s.e.), but there were no differences between groups in NTG (13.92±0.84% vs 15.11±0.96%, P ¼ 0.31) (±s.e.) (Figure 4 ).
Discussion
For the first time, our study investigated the relationship between LAD, FMD and the number of TOD in patients with hypertension. In this study sample, increased LAD, male sex and higher PP were the independent predictors of FMD. LVH, larger waist size, longer history of hypertension and reduced FMD could be regarded as significant predictors of LAD enlargement. LAD was significantly enlarged when the total number of TOD increased.
M-mode LA dimension is simple, convenient and universally used in clinical practice and research studies. LA enlargement detected by echocardiography is a common finding in hypertensive patients. There is strong evidence that LA size enlargement is a good predictor of cardiovascular outcomes.
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Vaziri et al. 6 investigated 1849 male and 2152 female participants of the Framingham Heart Study and found that both systolic and PP were significantly associated with enlargement of LAD. Cuspidi et al. 22 assessed 519 grade 1 and 2 hypertensive patients. In their multivariate analysis, overweight, LVH and IMT thickening were each independently associated with LAD enlargement. In other studies, Galderisi et al. 23 found that BMI, average night-time diastolic BP and male sex were independent predictors of LA size; Gottdiener et al. 24 showed that obesity is the strongest predictor of LA size in patients with hypertension. In this study, we confirmed that LAD correlated with age, BMI, waist size, waist-hip ratio, SBP, PP, the duration of hypertension, hypersensitive C-reactive protein, HDL-C and FMD. In multiple linear regression analysis, only LVMI, waist size, history of hypertension and FMD were significantly associated with LAD. Thus, the results of our study are in contrast to those of Gottdiener et al. 24 Possible reasons for this controversy may be that the two studies had different study populations and different independent variables. We observed that larger LA size was correlated with reduced FMD, suggesting that impaired endothelial function might be an important factor leading to LA enlargement in hypertensive patients. To confirm this hypothesis, we recommend a follow-up study that involves a larger patient cohort.
To our knowledge, this study is the first to report the relationship between the number of TOD and the 15 were used in our study. We found that LAD was positively associated with the number of TOD. As the total number of TOD increased, LAD was significantly enlarged. In our study, there was a significant relationship between LAD and serum creatinine, UACR, cf-PWV, IMT and LVMI. In this study population, the prevalence of LAD enlargement, alterations in arterial stiffness, IMT thickening or plaque buildup, LVH, microalbuminuria and a slight increase in serum creatinine was 50.8, 49.4, 40.1, 38.7, 24.7 and 1.6%, respectively. On the basis of these results, we propose that enlargement of LAD may be an early indicator and a new marker of TOD in this population.
FMD of the brachial artery is a marker of endothelial function. Many studies have investigated the relationship between FMD, cardiovascular risk factors and TOD. [25] [26] [27] [28] In our study, the relationship between FMD and LAD was investigated; after adjustment for traditional cardiovascular disease risk factors, we found that FMD was still significantly reduced in hypertensive patients with LAD enlargement. On multiple regression analysis, reduced FMD was independently associated with LAD enlargement, male sex and higher PP. FMD is a widely used method for the evaluation of endothelial function; however, there are technical and interpretive limitations of this technique. It is well known that M-mode LA diameter is easy to acquire compared with FMD. Thus, we suggested that detection of LA size may provide an easier and more convenient method to predict endothelial function.
In conclusion, this study offers evidence that enlargement of LAD may be an important predictor of endothelial dysfunction and may be considered an early indicator for evaluating TOD in hypertensive patients. Detection of LA size may provide an easier and more convenient method to predict endothelial function.
Study limitations
Several limitations must be acknowledged. First, the study subjects were hypertensive patients; they were using antihypertensive medications that have some effect on endothelial function. However, drug administration was suspended at least 24 h before the measurement of FMD. In addition, both groups of patients that we compared in this study were on similar drug regimens, so we believe that the effects of these drugs on FMD results were likely minimal. Second, a single LA dimension obtained by twodimensional targeted M-mode echocardiogram that represents the anterio-posterior diameter may not accurately reflect the true LA chamber in most patients. LA volume may be more precise, but LAD is a valid surrogate of LA size. It is more easily obtainable than LA volume, and measurement of LA diameter already forms part of the standard echocardiographic evaluation. Some large populationbased cohort studies, such Strong Heart Study 3 and the Losartan Intervention For End point, 4 used LA diameter as a surrogate of LA size. Third, because diastolic dysfunction is strongly correlated with LA enlargement, our assessment of diastolic dysfunction did not include a tissue Doppler image, which reflects a more accurate assessment of LV diastolic properties. Finally, our study population was relatively small, and the number of diabetic subjects in this sample was too small to detect difference with confidence.
What is known about topic K Left atrial size is associated with the presence of cardiovascular disease [1] [2] [3] [4] and it may be an early sign of patients with hypertensive heart disease.
5
K Flow-mediated dilation is an appropriate method to study endothelial function. Reduced FMD was associated with the number of target organ damage (TOD) and may be considered an indicator for evaluating TOD. 13 What this study adds K Enlargement of left atrial diameter (LAD) may be an important predictor of endothelial dysfunction. K LAD enlargement may be considered to be an indicator for evaluating TOD in hypertensive patients.
